Meli Pharm SRL
Meli Pharm reported total assets of 224,525 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Meli Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +574 % Total assets +431 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Meli Pharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 27 Nov 2025
- Year ended 31 Dec 2023filed on 26 Oct 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
Meli Pharm's financial analysis
- Solvency74.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Meli Pharm
Meli Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.989.972
- VAT number
- BE0789989972
- Peppol
- Registered · 0208:0789989972 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Aug 2022
- Registered office
- 1030 Schaerbeek
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Meli Pharm (SRL) has been based in Schaerbeek since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,056 € and equity of 166,293 €; its revenue is not published. Its solvency stands at 74.1%, above the median of its sector (37.8%).
Companies similar to Meli Pharm
Companies in the same business, of comparable size and area, outside its group.
- Kesters Pharma Invest Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet 469,134 €
- Apone Retail sale of pharmaceutical products Hemiksem · balance sheet 653,679 €
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Satilmis Retail sale of pharmaceutical products Saint-Gilles · balance sheet 304,962 €
- Shana Van Boom Other business support service activities n.e.c. Herselt · balance sheet 286,019 €
- Valerie Heylen Other business support service activities n.e.c. Heist-op-den-Berg · balance sheet 305,778 €
- Camba-Pharma Retail sale of pharmaceutical products Ghent · balance sheet 437,825 €
- Apotheek DE Lieve Retail sale of pharmaceutical products Lievegem · balance sheet 418,337 €
Frequently asked questions about Meli Pharm
What is the revenue of Meli Pharm?
Meli Pharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Meli Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0789989972 for Meli Pharm, if the company is VAT-registered. Its company number (CBE) is 0789.989.972.
Where is the registered office of Meli Pharm?
According to the CBE register, the registered office of Meli Pharm is in 1030 Schaerbeek.
What is the equity of Meli Pharm?
At the close of the 2025 financial year, the equity of Meli Pharm amounts to 166,293 €, a solvency of 74.1% of total assets.
Who manages Meli Pharm?
The register lists 3 active mandates at Meli Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Meli Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →